Press Release: MorphoSys AG: Publication pursuant to --26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution

MorphoSys AG / MorphoSys AG: Publication pursuant to --26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement.

X Notification of Major Holdings or Correction of a notification of Major Holding published on (date of publication)([i] #_edn1)

1. Details of issuer (name, address) MorphoSys AG Lena-Christ-Str. 48, 82152 Martinsried/Planegg, Germany

2. Reason for notification (multiple reasons possible)([ii] #_edn2) X Acquisition/disposal of shares with voting rights Acquisition/disposal of instruments Change of breakdown of voting rights([iii] #_edn3) Other reason([iv] #_edn4) :

3. Details of person subject to the notification obligation([v] #_edn5)

Name:([vi] #_edn6) City and country of registered office([vii] #_edn7) Mr. Mark N. Lampert (if applicable):

4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.([viii] #_edn8)

5. Date on which threshold was crossed or reached:([ix] #_edn9) 17.11.2016

6. Total positions Total % of voting number of rights Total of voting attached to both in % rights of shares (total % of voting rights through instruments (7.a. + issuer([x] of 7.a.) (total of 7.b.1. + 7.b.2.) 7.b.) #_edn10) Resulting situation 4,17% 0% 4,17% 29.159.770 Previous notification n/a% n/a% n/a% (if applicable)([xi] #_edn11)

7. Notified details of the resulting situation a. Voting rights attached to shares (Sec. 21, 22 WpHG) ISIN([xii] #_edn12) absolute in % direct indirect direct indirect (Sec. 21 WpHG) (Sec. 22 WpHG) (Sec. 21 WpHG) (Sec. 22 WpHG) DE0006632003 1214982 0% 4,17% % % Total 1214982 4,17%

b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG (please use annex in case of more than 3 instruments) Type of Expiration Exercise or Voting Voting rights in % instrument([xiii] or maturity conversion rights #_edn13) date period absolute % % % Total %

b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG (please use annex in case of more than 3 instruments) Type of Expiration Exercise Cash or Voting Voting rights in % instrument([xiv] or or physical rights #_edn14) maturity conversion settlement([xv] absolute date period #_edn15) % % % Total %

8. Information in relation to the person subject to the notification obligation (please tick the applicable box): Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity([xvi] #_edn16) (in case of more than 4 undertakings an annex is requested; the annex can be either a table or a qualified organizational chart; a qualified organizational chart contains only the information of a table; in case of a table please always provide only to BaFin also a basic organizational chart([xvii] #_edn17) ): Name % of voting rights % of voting rights through instruments Total of both (if at least held 3% or more) (if at least held 5% or more) (if at least held 5% or more) Mark N. % % % Lampert BVF Inc. % % % BVF Partners, % % % L.P. Biotechnology % % % Value Fund, L.P.

9. In case of proxy voting according to Sec. 22 para. 3 WpHG (only in case of attribution of voting rights pursuant to Sec. 22 para. 1 sent. 1 No. 6 WpHG) Date of general meeting: Holding position after general meeting: % (equals voting rights)([xviii] #_edn18)

10. Other useful information([xix] #_edn19)

Attachment to (please tick the applicable box)

II.7.b.1 (fill in the sums into the standard form)

7.b.1. Instrumente i.S.d. Sec. 25 para. 1 No. 1 WpHG (attachment can be extended) Voting Voting Expiration Exercise or conversion period Type of instrument rights rights or absolute in % maturity date % % % % % %

II.7.b.2 (fill in the sums into the standard form)

7.b.2. Instrumente i.S.d. Sec. 25 Abs. 1 No. 2 WpHG (attachment can be extended) Expiration Cash or physical settlement Type of instrument Voting rights absolute Voting rights in % or Exercise or conversion period maturity date % % % % % %

X II.8. (Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity; attachment can be extended)

% of voting rights through instruments Name % of voting rights (if at least held 5% or more) Total of both (if at least held 3% or more) (if at least held 5% or more) Mark N. % % % Lampert BVF Inc. % % % BVF Partners, % % % L.P. Biotechnology % % % Value Fund II, L.P.

Mark N. % % % Lampert BVF Inc. % % % BVF Partners, % % % L.P. BVF Partners % % % OS Ltd. Biotechnology % % % Value Trading Fund OS L.P.

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: MorphoSys AG via Globenewswire

--- End of Message ---

MorphoSys AG

Lena-Christ-Str. 48 Martinsried / Munich Germany

WKN: 663200;ISIN: DE0006632003;Index:TECH All Share,CDAX,Prime All Share, TecDAX,HDAX,MIDCAP;

Listed: Freiverkehr in Börse Stuttgart,

Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,

Freiverkehr in Börse Berlin,

Freiverkehr in Börse Düsseldorf,

Freiverkehr in Bayerische Börse München,

Freiverkehr in Niedersächsische Börse zu Hannover,

Prime Standard in Frankfurter Wertpapierbörse,

Regulierter Markt in Frankfurter Wertpapierbörse;

http://www.morphosys.com (END) Dow Jones Newswires

   November 25, 2016 08:05 ET (13:05 GMT)- - 08 05 AM EST 11-25-16